Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
Recruiting
N/A
Interventional Study
Heart Failure
Left Ventricular Dysfunction
Idiopathic Dilated Cardiomyopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 190 (estimated)
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients presenting with idiopathic dilated cardiomyopathy and left ventricle dysfunction (LVEF \<40%), naive of anti-remodeling cardiac medical therapy, will undergo invasive coronary microvascular assessment based on thermodilution. The primary endpoint, namely the left ventricle reverse remodeling, will be assessed after 12 months of optimal medical therapy based on transthoracic echocardiograp…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female, aged \>18 years
* First diagnosis of idiopathic DCM (defined according to the most recent ESC Guidelines) with LVEF ≤ 40% and clinical indication to diagnostic coronary angiography
* Willing and able to give informed consent for participation in the study
Excl…
Contacts